Investor Ideas Potcasts, Cannabis News and Stocks on the Move: Oklahoma, Australia and Continued Cannabis Stigmas
Vancouver, Delta, Kelowna, BC - March 9, 2023 (Investorideas.com Newswire) investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts, Cannabis News and Stocks on the Move: Oklahoma, Australia and Continued Cannabis Stigmas
Today's podcast overview/transcript:
In today's podcast we look at Oklahoma's rejection of recreational cannabis, roadside testing in Australia and the issues surrounding roadside testing in legal cannabis jurisdictions and the continued use of outdated cannabis stigmas
In recent news, Oklahoma rejected a new ballot intended to bring recreational cannabis to the state. The state, which currently has a growing medical cannabis industry, rejected the recent ballot question that would have allowed dispensaries across the state to sell cannabis to anyone over the age of 21.
The proposal was widely opposed by law enforcement, school administrators, and political and faith leaders.
About 10% of the adult population now has a medical licence, but the programme has been plagued by illegal growers, headline-grabbing crimes and a deluge of out-of-state consumers.
Pat McFerron, an advisor to the No 820 campaign, said the vote "sends a clear message that Oklahomans oppose the unfettered access to marijuana we have experienced under our so-called medical programme".
"Oklahoma is a law and order state," added Governor Kevin Stitt, a Republican who also opposed the measure. He vowed to "continue to hold bad actors accountable and crack down on illegal marijuana operations".
"Today's decision in Oklahoma is heartbreaking, especially considering how many challenges this bill faced before it got to the ballot and how much work advocates put in," said Jeffrey M. Zucker, co-founder and president of Denver-based cannabis consultancy Green Lion Partners and vice chair of the board at the Marijuana Policy Project, a national legalisation advocacy group.
"We have a long way to go to undo the damage of the war on drugs, especially in a state where more than 4,500 people are arrested annually for cannabis possession," he added.
Last November, similar cannabis referendums were approved in Maryland and Missouri, but defeated in Arkansas, North Dakota and South Dakota.
In other news coming from Australia, Victoria's drug-driving laws are set to be overhauled for medicinal cannabis users, with both major parties backing a push by Legalise Cannabis over the "unfair" rules.
Debate on the Road Safety Amendment (Medicinal Cannabis) bill, introduced by the newly elected Legalise Cannabis MPs, was adjourned on Wednesday after the government committed to addressing the issue within months.
The bill seeks to change the state's road safety laws to treat medicinal cannabis like other prescription medications for drivers. Currently, it is an offence for a person to drive with any trace of tetrahydrocannabinol (THC) in their system, even if they have a prescription from their doctor.
The Labor MP Harriet Shing, who is a member of the medicinal cannabis and safe driving working group established by the government, said finding a "distinction between presence [of THC] and impairment" was a "significant priority".
"This work has been going on for a number of years now. The working group has actually discussed at length the complexities of this matter and the options and opportunities that might be available," she told the upper house on Wednesday.
"We need ... to find a way through all of this so that all drivers are able to be safe on our roads and so that we can provide those medical supports that Victorians need and indeed deserve."
The opposition leader in the upper house, Matt Bach, said the Coalition viewed the current system as "unfair" and "inconsistent" for 65,000 Victorians currently prescribed medicinal cannabis.
This has been an issue raised in many US states with medical programs as well as in Canada since federal legislation. One of the key issues being looked at in all areas is the specifics surrounding roadside testing and accuracy of the various equipment being used, how THC is absorbed in the body and the length of time it stays in your system and the fact that this is a medical product prescribed for a variety of medical conditions, some of which are necessary for work, unlike alcohol or other drugs which are tested for on the road.
Finally we look at the continued use of either unfounded or outdated cannabis stigmas in a variety of news outlets and how these so called "news stories" continue to avoid much more serious issues caused by alcohol use, tobacco use, refined sugars and traditional pharmaceutical medications.
It takes only a brief search on any search platform, most notoriously Google, to find a variety of news articles and seudo-studies discussing the dangers of cannabis use, the unknowns of cannabis use, outdated stigmas and anti-cannabis propaganda.
Typing just simply "cannabis" into Google's search engine today brings up the following articles to list just a few.:
- "Long-Term Cannabis Use, Cognitive Decline, and the Hippocampus" from Psychology Today, an article which implies a direct correlation between cannabis use and cognitive decline, but also offers none of the original data, underplays the fact that most of this data is obtained from interviews and does not include the cross reference data from the control groups.
- "National Survey Reveals More Than One-Third of U.S. Women Consume Cannabis, But Stigmas Linger" from the Financial Post, which openly discusses how even though a large percentage of women admit to cannabis use privately, social stigmas keep them from admitting this openly, especially when looking at mothers.
- "Rise in people using cannabis to treat health conditions - but doctors warn patients are putting themselves at risk" from Sky News, which discusses how as more people continue to use cannabis in the UK, doctors warn users of the risks of illicit cannabis, even though while cannabis users can admit themselves to the hospital, for a supposed cannabis overdose, there have been no reported overdoses of cannabis, a drug which has been connected to human culture for thousands of years
If you're looking for articles which show much more realistic studies that have been conducted both long term and short term and have a much larger study group to go off of and discuss the vast potential of cannabis in reducing opioid addiction and overdoses, alcoholism, as well as anxiety, inflammation and depression, you have to go to cannabis devoted news sources like MJBizDaily, Marijuana Moment and Herb, to name a few.
It would be easy to argue there are biases on both sides of the argument, but the difference is the fear mongering surrounding cannabis is widely, if not entirely, unfounded. The criticism of pharmaceutical products like prescription opioids, which in 2021 had 16,706 deaths reported, alcohol, which is linked to more than 140,000 people (approximately 97,000 men and 43,000 women) deaths from alcohol-related causes annually, or refined sugars, specifically in beverages produced by companies such as Coca Cola and Pepsi, which a New Harvard School of Public Health (HSPH) research suggests that roughly 180,000 obesity-related deaths worldwide-including 25,000 Americans-are associated with the consumption of sugary drinks.
When compared to cannabis, which actually has more data that suggests that cannabis use appears to prevent approximately 17,400 to 38,500 premature deaths annually under current policies and an estimated 23,500 to 47,500 deaths which could be prevented annually if medical marijuana were legal nationwide.
This factual reality can seem impossible to believe when you consider that both alcohol, pharmaceutical products, some of which are being recommended for off-label use such as the recent news surrounding Ozempic, and refined sugar products are all allowed to be advertised nationally, if not globally, including on programming which minors can view, and are endorsed by government officials and regulatory bodies such as the FDA and CDC.
When looking at these facts and the transparent hypocrisy surrounding cannabis when compared to other openly legal substances, it's hard not to ask yourself, what are our world government's smoking? It certainly isn't weed.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts), Audible, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts and most audio platforms available.
About Investorideas.com - Big Investing Ideas
We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea's original branded content includes the Crypto Corner Podcast, Play by Play Sports Podcast, Cannabis News and Stocks on the Move Podcast, Cleantech and Climate Change Podcast, Exploring Mining Podcast, Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
800 665 0411